胰岛素抵抗伴高胰岛素血症作为心力衰竭发生和恶化的原因
Insulin Resistance with Associated Hyperinsulinemia as a Cause of the Development and Worsening of Heart Failure.
作者信息
Attanasio Umberto, Mercurio Valentina, Fazio Serafino
机构信息
Department of Translational Medical Sciences, Federico II University, 80131 Naples, Italy.
Department of Internal Medicine, School of Medicine, Federico II University, 80131 Naples, Italy.
出版信息
Biomedicines. 2024 Dec 19;12(12):2890. doi: 10.3390/biomedicines12122890.
Abstract
Despite the considerable progress that has been made with regard to the prevention and treatment of cardiovascular diseases, heart failure (HF) remains a particularly important cause of recurring hospitalizations, with relevant social and healthcare costs, and it is a significant cause of mortality; as such, there is a need for continuous efforts to improve our understanding of its complex pathophysiology and refine relevant therapeutic strategies [...].
摘要
尽管在心血管疾病的预防和治疗方面已经取得了相当大的进展，但心力衰竭（HF）仍然是再次住院的一个特别重要的原因，伴随着相关的社会和医疗成本，并且是一个重要的死亡原因；因此，需要持续努力以增进我们对其复杂病理生理学的理解并完善相关治疗策略[……]。
相似文献
1
Insulin Resistance with Associated Hyperinsulinemia as a Cause of the Development and Worsening of Heart Failure.胰岛素抵抗伴高胰岛素血症作为心力衰竭发生和恶化的原因
Biomedicines. 2024 Dec 19;12(12):2890. doi: 10.3390/biomedicines12122890.
2
Insulin Resistance/Hyperinsulinemia, Neglected Risk Factor for the Development and Worsening of Heart Failure with Preserved Ejection Fraction.胰岛素抵抗/高胰岛素血症，射血分数保留的心力衰竭发生和恶化的被忽视的危险因素。
Biomedicines. 2024 Apr 4;12(4):806. doi: 10.3390/biomedicines12040806.
3
The Negative Impact of Insulin Resistance/Hyperinsulinemia on Chronic Heart Failure and the Potential Benefits of Its Screening and Treatment.胰岛素抵抗/高胰岛素血症对慢性心力衰竭的负面影响及其筛查与治疗的潜在益处
Biomedicines. 2023 Oct 30;11(11):2928. doi: 10.3390/biomedicines11112928.
4
Real-World Economic Burden Among Patients With And Without Heart Failure Worsening After Cardiac Resynchronization Therapy.心脏再同步治疗后心力衰竭恶化患者与未恶化患者的真实世界经济负担。
Adv Ther. 2021 Jan;38(1):441-467. doi: 10.1007/s12325-020-01536-2. Epub 2020 Nov 3.
5
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).门诊治疗的心力衰竭临床恶化的重要性：来自血管紧张素受体脑啡肽酶抑制剂与血管紧张素转换酶抑制剂前瞻性比较以确定对心力衰竭试验全球死亡率和发病率影响的证据（PARADIGM-HF）
Circulation. 2016 Jun 7;133(23):2254-62. doi: 10.1161/CIRCULATIONAHA.115.020729. Epub 2016 Apr 20.
6
Impact of a heart failure multidisciplinary clinic on the reduction of healthcare-related events and costs: the GEstIC study.心力衰竭多学科诊所对减少医疗相关事件和成本的影响：GEstIC研究
Front Cardiovasc Med. 2023 Sep 29;10:1232291. doi: 10.3389/fcvm.2023.1232291. eCollection 2023.
7
Outpatient Worsening Heart Failure in Patients With Transthyretin Amyloidosis With Cardiomyopathy in the HELIOS-B Trial.HELIOS-B试验中甲状腺转运蛋白淀粉样变心肌病患者的门诊心力衰竭恶化情况
J Am Coll Cardiol. 2025 Feb 25;85(7):753-761. doi: 10.1016/j.jacc.2024.11.015. Epub 2024 Nov 18.
8
Community-based care for the specialized management of heart failure: an evidence-based analysis.基于社区的心力衰竭专科管理：一项循证分析
Ont Health Technol Assess Ser. 2009;9(17):1-42. Epub 2009 Nov 1.
9
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study.依伐布雷定对慢性收缩性心力衰竭患者因心力衰竭恶化而再住院的影响：SHIFT 研究。
Eur Heart J. 2012 Nov;33(22):2813-20. doi: 10.1093/eurheartj/ehs259. Epub 2012 Aug 27.
10
Sotagliflozin vs Dapagliflozin: A Systematic Review Comparing Cardiovascular Mortality.索格列净与达格列净对比：一项比较心血管死亡率的系统评价
Cureus. 2023 Sep 19;15(9):e45525. doi: 10.7759/cureus.45525. eCollection 2023 Sep.
引用本文的文献
1
Relationship between stress hyperglycemia ratio of one-year mortality in patients with heart failure: Analysis of the MIMIC-IV database.心力衰竭患者应激性高血糖与一年死亡率的关系：MIMIC-IV数据库分析
PLoS One. 2025 Aug 8;20(8):e0328812. doi: 10.1371/journal.pone.0328812. eCollection 2025.
本文引用的文献
1
Association between Serum Free Fatty Acids and Clinical and Laboratory Parameters in Acute Heart Failure Patients.急性心力衰竭患者血清游离脂肪酸与临床及实验室参数之间的关联
Biomedicines. 2023 Dec 1;11(12):3197. doi: 10.3390/biomedicines11123197.
2
The Negative Impact of Insulin Resistance/Hyperinsulinemia on Chronic Heart Failure and the Potential Benefits of Its Screening and Treatment.胰岛素抵抗/高胰岛素血症对慢性心力衰竭的负面影响及其筛查与治疗的潜在益处
Biomedicines. 2023 Oct 30;11(11):2928. doi: 10.3390/biomedicines11112928.
3
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会（HFA）特别贡献制定。
Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.
4
Insulin resistance: Is it time for primary prevention?胰岛素抵抗：是时候进行一级预防了吗？
World J Cardiol. 2012 Jan 26;4(1):1-7. doi: 10.4330/wjc.v4.i1.1.
Zotero 插件